| Literature DB >> 21258449 |
Sophie Piper, Peyman Bahmani, Jan Klohs, Riad Bourayou, Peter Brunecker, Jochen Müller, Denise Harhausen, Ute Lindauer, Ulrich Dirnagl, Jens Steinbrink, Andreas Wunder.
Abstract
Non-invasive near-infrared fluorescence (NIRF) imaging is a powerful tool to study pathophysiology in a wide variety of animal disease models including brain diseases. However, especially in NIRF imaging of the brain or other deeper laying target sites, background fluorescence emitted from the scalp or superficial blood vessels can impede the detection of fluorescence in deeper tissue. Here, we introduce an effective method to reduce the impact of fluorescence from superficial layers. The approach uses excitation light at two different wavelengths generating two images with different depth sensitivities followed by an adapted subtraction algorithm. This technique leads to significant enhancement of the contrast and the detectability of fluorochromes located in deep tissue layers in tissue simulating phantoms and murine models with stroke.Entities:
Year: 2010 PMID: 21258449 PMCID: PMC3005168 DOI: 10.1364/BOE.1.000097
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732
Fig. 2Color-coded NIRF images of the tissue phantom study. Capsules containing NIRF dye Cy5.5 embedded in meat as sketched in a vertical view in the first column. Images with illumination at 670 (left) or 633 nm (middle), and the resulting depth-weighted images (right) are shown. The red circles indicate the position of the fluorescent target. (a) capsule located 4 mm below the surface. (b) capsule located 8 mm below the surface. The asterisk indicates an area of strong superficial tissue autofluorescence, which is strongly reduced in the depth-weighted image. (c) capsule located 8 mm below the surface and a dye solution is applied topically on the surface. The color bars represent relative fluorescence intensities (arbitrary units).
Fig. 3Non-invasive NIRF images of a live mouse implanted with an intracranial capsule containing 10−12 mol Cy5.5-PEG. Images after illumination with light of 670 or 633 nm wavelengths, and the resulting depth-weighted images are depicted. (a) before and (b) after i.v.-injection of 2 x 10−10mol Cy5.5-PEG.
Fig. 4Non-invasive NIRF images of a live mouse after experimentally induced cerebral ischemia in the left hemisphere 2 h after i.v.-injection of NIRF-labeled albumin.
Fig. 1Monte-Carlo results. (a) Normalized sensitivity in a logarithmic scale as a function of depth for a point inclusion fluorescing at 710 nm, spread excitation beams at 633 nm and 670 nm and a point-wise detection. This mimics the spread excitation of a fluorescent source in an epi-fluorescence imaging system and the detection with a camera system. (b) Quotient of the normalized sensitivities shown in (a).